Found 13 matching trials
Investigating the Clinical Consequences of Flutemetamol-PET-scanning
PHASE3The study examines subjects where there might be an indication for Amyloid-...
Location
University of Zurich, Institute for Regenerative Medicine, Center for Prevention and Dementia Therapy
Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy
PHASE118F-Flutemetamol (Vizamyl) is a radioactive diagnostic agent indicated and ...
Implications for Management of PET Amyloid Classification Technology
N/AThe main purpose of this study is to explore the impact of an amyloid posit...
Location
Center for Alzheimer's Care, Imaging & Research
Applying PET/MR for Dementia Applications
NADementia is a common disorder affecting about 50 million people worldwide w...
Location
Multiple Locations
Bridging Study of C11 Pittsburgh Compound B (PiB) and F18 Flutemetamol Brain Positron Emission Tomography (PET)
PHASE2The intent of this research protocol is to test the equivalency of two amyl...
Location
Mayo Clinic Rochester
The Swedish BioFINDER 2 Study
NAThe Swedish BioFINDER 2 study is a new study that will launch in 2017 and e...
Location
Memory Clinic, Hospital of Ängelholm
Assessment of Cardiac Fixation During PET Using a New Drug Within Amyloid Cardiac Injuries.
EARLY_PHASE1To estimate distribution's parameters of 18F-Flutemetamol (Vizamyl®) fixati...
Location
University Hospital Toulouse
The Swedish BioFINDER - Preclinical AD Study
N/AThis research study aims to examine biomarkers of Alzheimer's disease (AD) ...
Location
Skåne University Hospital
Comparison of PET Amyloid Imaging in Japanese and Western Subjects
PHASE2This was a Phase 2, multicenter study to assess the extent and patterns of ...
Location
Multiple Locations
BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers
N/AThis research study aims to examine biomarkers of Alzheimer's disease as ea...
Status
Enrolling By Invitation
Location
Butler Hospital Memory and Aging Program